High FOXA1 levels induce ER transcriptional reprogramming,a pro-metastatic secretome,and metastasis in endocrine-resistant breast cancer
Affiliation:
1. Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA;2. Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA;3. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA;4. Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA;5. Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy;6. Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA;7. Department of Bioinformatics, Semmelweis University, 1085 Budapest, Hungary;8. RCNS Cancer Biomarker Research Group, Institute of Enzymology, Magyar Tudósok körútja 2, 1117 Budapest, Hungary;9. Department of Pharmacy Practice and Translational Research, University of Houston, Houston, TX 77204, USA;10. Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX 77204, USA;11. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02210, USA;12. Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA;13. Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva 84105, Israel;14. Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02210, USA
